CRI
IHE icon

Commonwealth Retirement Investments’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Commonwealth Retirement Investments’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$294K Sell
2,967
-323
-10% -$29.1K 0.08% 111
2026
Q1 		$285K Sell
3,290
-2,856
-46% -$250K 0.09% 111
2025
Q4 		$521K Buy
+6,146
New +$491K 0.17% 92
2025
Q1 		– Sell
-8,157
Closed -$536K – 100
2024
Q4 		$536K Buy
+8,157
New +$561K 0.22% 77

Other funds holding IHE

Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
IWS
Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return
MCM
Monument Capital Management Alexandria, Virginia $497M AUM 52.58% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return
AWM
Accurate Wealth Management Wesley Chapel, Florida $1.05B AUM 30.92% 1-Year Est. Return
FP
FFG Partners Fort Lauderdale, Florida $352M AUM 70.53% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
AFG
Arkansas Financial Group Little Rock, Arkansas $768M AUM 16.55% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

Commonwealth Retirement Investments's IHE Position: Q2 2026 in Review

Commonwealth Retirement Investments reduced its iShares US Pharmaceuticals ETF (IHE) stake by 9.8% in Q2 2026, selling an estimated $29.1K and leaving 2,967 shares worth $294K. The position accounts for 0.08% of the portfolio, ranked #111.

Commonwealth Retirement Investments first reported a position in IHE in Q4 2024 and has held it in 4 quarters since. The position peaked at $536K in Q4 2024. 91 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

  • Commonwealth Retirement Investments held 2,967 shares of iShares US Pharmaceuticals ETF worth $294K as of Q2 2026.
  • Commonwealth Retirement Investments sold 323 iShares US Pharmaceuticals ETF shares in Q2 2026, an estimated $29.1K.
  • iShares US Pharmaceuticals ETF made up 0.08% of Commonwealth Retirement Investments's portfolio in Q2 2026, its #111 holding.
  • Commonwealth Retirement Investments first reported a position in iShares US Pharmaceuticals ETF in Q4 2024 and has held it in 4 quarters since.
  • Commonwealth Retirement Investments's iShares US Pharmaceuticals ETF position peaked at $536K in Q4 2024.
  • 91 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on Commonwealth Retirement Investments's 13F filing for Q2 2026, filed 3 Aug 2026.